Southwest Private Capital Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-04-25 4:05 pm Purchase |
2022-04-14 | 13G | BriaCell Therapeutics Corp. BCTX |
Southwest Private Capital Inc. | 52,134 5.100% |
52,134![]() (New Position) |
Filing |